Theralink Technologies, Inc.
THER · OTC
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -11.4% | 0% | 19.2% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 77.7% | 75.3% | 75.3% | 85% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $2 | $2 | $2 | $2 |
| SG&A Expenses | $2 | $2 | $2 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $1 | $1 | $0 |
| Operating Expenses | $2 | $2 | $2 | $2 |
| Operating Income | -$2 | -$2 | -$2 | -$2 |
| % Margin | -1,302.9% | -949.2% | -949.2% | -1,264.1% |
| Other Income/Exp. Net | $17 | $11 | $11 | -$6 |
| Pre-Tax Income | $10 | $5 | $5 | -$9 |
| Tax Expense | $5 | $5 | $5 | $11 |
| Net Income | $10 | $5 | $5 | -$20 |
| % Margin | 5,363.6% | 2,222.8% | 2,222.8% | -11,707.9% |
| EPS | 0.16 | 0.073 | 0.073 | -0.32 |
| % Growth | 118.6% | 0% | 122.9% | – |
| EPS Diluted | 0.002 | 0 | 0 | -0.003 |
| Weighted Avg Shares Out | 62 | 62 | 62 | 62 |
| Weighted Avg Shares Out Dil | 6,151 | 6,151 | 6,151 | 6,151 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $5 | $5 | $5 | $5 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$2 | -$2 | -$2 | -$2 |
| % Margin | -1,385.7% | -805.6% | -805.6% | -1,232.2% |